RZLT
Price
$5.39
Change
-$0.15 (-2.71%)
Updated
Jul 18 closing price
Capitalization
467.93M
52 days until earnings call
SNBIF
Price
$14.28
Change
+$7.73 (+118.02%)
Updated
Jul 15 closing price
Capitalization
1.03B
Interact to see
Advertisement

RZLT vs SNBIF

Header iconRZLT vs SNBIF Comparison
Open Charts RZLT vs SNBIFBanner chart's image
Rezolute
Price$5.39
Change-$0.15 (-2.71%)
Volume$664.15K
Capitalization467.93M
Sanbio
Price$14.28
Change+$7.73 (+118.02%)
Volume$544
Capitalization1.03B
RZLT vs SNBIF Comparison Chart in %
Loading...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RZLT vs. SNBIF commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RZLT is a Hold and SNBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (RZLT: $5.39 vs. SNBIF: $14.28)
Brand notoriety: RZLT and SNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RZLT: 59% vs. SNBIF: 236%
Market capitalization -- RZLT: $467.93M vs. SNBIF: $1.03B
RZLT [@Biotechnology] is valued at $467.93M. SNBIF’s [@Biotechnology] market capitalization is $1.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RZLT’s FA Score shows that 0 FA rating(s) are green whileSNBIF’s FA Score has 0 green FA rating(s).

  • RZLT’s FA Score: 0 green, 5 red.
  • SNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, RZLT is a better buy in the long-term than SNBIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RZLT’s TA Score shows that 4 TA indicator(s) are bullish while SNBIF’s TA Score has 1 bullish TA indicator(s).

  • RZLT’s TA Score: 4 bullish, 3 bearish.
  • SNBIF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, RZLT is a better buy in the short-term than SNBIF.

Price Growth

RZLT (@Biotechnology) experienced а +2.47% price change this week, while SNBIF (@Biotechnology) price change was +118.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

RZLT is expected to report earnings on Sep 11, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNBIF($1.03B) has a higher market cap than RZLT($468M). SNBIF YTD gains are higher at: 207.097 vs. RZLT (10.000). RZLT has higher annual earnings (EBITDA): -77.12M vs. SNBIF (-2.99B). RZLT (0) and SNBIF (0) have equivalent revenues.
RZLTSNBIFRZLT / SNBIF
Capitalization468M1.03B46%
EBITDA-77.12M-2.99B3%
Gain YTD10.000207.0975%
P/E RatioN/AN/A-
Revenue00-
Total Cash86.9MN/A-
Total Debt1.78MN/A-
FUNDAMENTALS RATINGS
RZLT vs SNBIF: Fundamental Ratings
RZLT
SNBIF
OUTLOOK RATING
1..100
4450
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
3734
P/E GROWTH RATING
1..100
10067
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (50) in the null industry is somewhat better than the same rating for SNBIF (96). This means that RZLT’s stock grew somewhat faster than SNBIF’s over the last 12 months.

RZLT's Profit vs Risk Rating (100) in the null industry is in the same range as SNBIF (100). This means that RZLT’s stock grew similarly to SNBIF’s over the last 12 months.

RZLT's SMR Rating (98) in the null industry is in the same range as SNBIF (99). This means that RZLT’s stock grew similarly to SNBIF’s over the last 12 months.

SNBIF's Price Growth Rating (34) in the null industry is in the same range as RZLT (37). This means that SNBIF’s stock grew similarly to RZLT’s over the last 12 months.

SNBIF's P/E Growth Rating (67) in the null industry is somewhat better than the same rating for RZLT (100). This means that SNBIF’s stock grew somewhat faster than RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RZLTSNBIF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
36%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
29%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
12%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
7%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIBIX30.540.06
+0.20%
Thornburg Investment Income Builder I
PCMSX16.08-0.01
-0.06%
Principal MidCap Value I R6
ITETX9.72-0.02
-0.21%
VY® T. Rowe Price Equity Income S2
PCEQX24.30-0.06
-0.25%
Victory Pioneer Equity Income C
MMECX23.75-0.12
-0.50%
Victory Integrity Discovery C

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
-2.71%
RLAY - RZLT
47%
Loosely correlated
-4.11%
XNCR - RZLT
44%
Loosely correlated
-1.10%
CRNX - RZLT
41%
Loosely correlated
-5.78%
ATYR - RZLT
41%
Loosely correlated
+3.45%
TERN - RZLT
40%
Loosely correlated
+0.71%
More

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with AZTR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
AZTR - SNBIF
46%
Loosely correlated
-0.22%
RENB - SNBIF
34%
Loosely correlated
+0.57%
ANTX - SNBIF
33%
Loosely correlated
+0.92%
SONN - SNBIF
28%
Poorly correlated
-20.67%
RZLT - SNBIF
5%
Poorly correlated
-2.71%
More